全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Everolimus plus long-acting somatostatin analogs in thymic epithelial malignancies

DOI: 10.5306/wjco.v3.i7.111

Keywords: Thymoma , Everolimus , mTOR , Mediastinum , Target

Full-Text   Cite this paper   Add to My Lib

Abstract:

Although thymic epithelial tumors (TETs) are rare in the general population, they represent the most frequently diagnosed primary malignant tumor of the anterior mediastinum. Unlike localized disease, metastatic disease is invariably fatal. While several chemotherapy agents have proven to be effective in TETs, somatostatin analogs are the only targeted agents with an established role in this disease. Everolimus is an mTOR inhibitor with multiple application in oncology. In this report, we show for the first time that everolimus was effective in two heavily pretreated patients with advanced TETs, with a progression-free survival longer than 1 year and minimal toxicity.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133